Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism

OBJECTIVE: Apolipoprotein (apo)CIII inhibits lipoprotein lipase (LpL)-mediated lipolysis of very low density lipoprotein (VLDL) TG and decreases hepatic uptake of VLDL remnants. The discovery that 5% of Lancaster Old Order Amish are heterozygous for the APOC3 R19X null mutation provided the opportun...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arterioscler Thromb Vasc Biol
Autors principals: Reyes-Soffer, Gissette, Sztalryd, Carol, Horenstein, Richard B., Holleran, Stephen, Matveyenko, Anastasiya, Thomas, Tiffany, Nandakumar, Renu, Ngai, Colleen, Karmally, Wahida, Ginsberg, Henry N, Ramakrishnan, Rajasekhar, Pollin, Toni I.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6309928/
https://ncbi.nlm.nih.gov/pubmed/30580564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.118.311476
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars